Literature DB >> 18058942

Increased plasma membrane localization of O-glycosylation-deficient mutant of synaptotagmin I in PC12 cells.

Eiko Kanno1, Mitsunori Fukuda.   

Abstract

Synaptotagmin I (Syt I) is a Ca2+-binding protein on synaptic vesicles and presumably functions as a Ca2+ sensor for neurotransmitter release. Native Syt I protein in neuroendocrine PC12 cells undergoes several posttranslational modifications, such as O-glycosylation, N-glycosylation, and fatty acylation, and the latter two modifications have been shown to be required for the proper function of murine Syt I in PC12 cells. However, nothing is known about the physiological significance of the O-glycosylation of Syt I in dense-core vesicle exocytosis in PC12 cells. In this study, we created an O-glycosylation-deficient mutant (named TA = T15A/T16A) and an N-glycosylation-deficient mutant of Syt I (named T26A) and investigated their subcellular distribution in Syt I-deficient PC12 cells, where other Syt isoforms (e.g., IV and IX) and other membrane trafficking proteins (e.g., Rab27A, SNAP-25, syntaxin-1, and VAMP-2) are normally expressed. We found that some cells expressing high level of recombinant wild-type (WT) Syt I protein show mistargeting of Syt I(WT) protein to the plasma membrane, whereas most of the cells show normal dense-core vesicle localization of Syt I(WT) protein. Similar mistargeting was also observed in cells expressing high levels of the Syt I(T26A) and Syt I(TA) mutants, but the mistargeting of the Syt I(TA) mutant to the plasma membrane was much more evident than with the Syt I(WT) or (T26A) mutant. The results indicate that O-glycosylation, not N-glycosylation, is partially involved in efficient targeting of Syt I protein to dense-core vesicles in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058942     DOI: 10.1002/jnr.21568

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

1.  Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.

Authors:  Shiri Moshitzky; Carol Asher; Haim Garty
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Vesicle-Mediated Steroid Hormone Secretion in Drosophila melanogaster.

Authors:  Naoki Yamanaka; Guillermo Marqués; Michael B O'Connor
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

3.  Palmitoylation-dependent association with CD63 targets the Ca2+ sensor synaptotagmin VII to lysosomes.

Authors:  Andrew R Flannery; Cecilia Czibener; Norma W Andrews
Journal:  J Cell Biol       Date:  2010-11-01       Impact factor: 10.539

4.  Post-translational modifications and lipid binding profile of insect cell-expressed full-length mammalian synaptotagmin 1.

Authors:  Marija Vrljic; Pavel Strop; Ryan C Hill; Kirk C Hansen; Steven Chu; Axel T Brunger
Journal:  Biochemistry       Date:  2011-10-26       Impact factor: 3.162

Review 5.  The high-affinity calcium sensor synaptotagmin-7 serves multiple roles in regulated exocytosis.

Authors:  Daniel D MacDougall; Zesen Lin; Nara L Chon; Skyler L Jackman; Hai Lin; Jefferson D Knight; Arun Anantharam
Journal:  J Gen Physiol       Date:  2018-05-24       Impact factor: 4.086

6.  A manual collection of Syt, Esyt, Rph3a, Rph3al, Doc2, and Dblc2 genes from 46 metazoan genomes--an open access resource for neuroscience and evolutionary biology.

Authors:  Molly Craxton
Journal:  BMC Genomics       Date:  2010-01-15       Impact factor: 3.969

7.  Glycosylation is dispensable for sorting of synaptotagmin 1 but is critical for targeting of SV2 and synaptophysin to recycling synaptic vesicles.

Authors:  Sung E Kwon; Edwin R Chapman
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

8.  Use of biotinylated ubiquitin for analysis of rat brain mitochondrial proteome and interactome.

Authors:  Olga A Buneeva; Marina V Medvedeva; Arthur T Kopylov; Victor G Zgoda; Alexei E Medvedev
Journal:  Int J Mol Sci       Date:  2012-09-14       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.